Undeca-1,5-dien-3-ol
General Information
Chemical name | Undeca-1,5-dien-3-ol |
CAS number | 56722-23-7 |
Flavouring type | substances |
FL No. | 02.211 |
Mixture | No |
Purity of the named substance at least 95% unless otherwise specified |
From webgate.ec.europa.eu
Computed Descriptors
Download SDF2D Structure | |
CID | 53981988 |
IUPAC Name | undeca-1,5-dien-3-ol |
InChI | InChI=1S/C11H20O/c1-3-5-6-7-8-9-10-11(12)4-2/h4,8-9,11-12H,2-3,5-7,10H2,1H3 |
InChI Key | JYWXEBALSPBIIA-UHFFFAOYSA-N |
Canonical SMILES | CCCCCC=CCC(C=C)O |
Molecular Formula | C11H20O |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 168.28 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 7 |
Complexity | 127.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A C B S g g A I C A A A A A g C A A C B C A A A A A A A g A A A I C A A A A A g A F A I A A Q A A Q A A A w A A I E A M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 20.2 |
Monoisotopic Mass | 168.151 |
Exact Mass | 168.151 |
XLogP3 | None |
XLogP3-AA | 3.6 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 12 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 1 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9628 |
Human Intestinal Absorption | HIA+ | 0.9927 |
Caco-2 Permeability | Caco2+ | 0.8142 |
P-glycoprotein Substrate | Non-substrate | 0.5970 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7749 |
Non-inhibitor | 0.8048 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9008 |
Distribution | ||
Subcellular localization | Plasma membrane | 0.3896 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8178 |
CYP450 2D6 Substrate | Non-substrate | 0.8621 |
CYP450 3A4 Substrate | Non-substrate | 0.6680 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6776 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9263 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9472 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9047 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9416 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8395 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6989 |
Non-inhibitor | 0.8150 | |
AMES Toxicity | Non AMES toxic | 0.9423 |
Carcinogens | Carcinogens | 0.5394 |
Fish Toxicity | High FHMT | 0.9746 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7870 |
Honey Bee Toxicity | High HBT | 0.7630 |
Biodegradation | Ready biodegradable | 0.6805 |
Acute Oral Toxicity | III | 0.5408 |
Carcinogenicity (Three-class) | Non-required | 0.7453 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.7022 | LogS |
Caco-2 Permeability | 1.2403 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.0278 | LD50, mol/kg |
Fish Toxicity | -0.1648 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.6917 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty alcohols |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty alcohols |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Fatty alcohol - Secondary alcohol - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Alcohol - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty alcohols. These are aliphatic alcohols consisting of a chain of a least six carbon atoms. |
From ClassyFire